Carl Zeiss Meditec AG (ETR:AFX)
32.16
-0.72 (-2.19%)
Sep 3, 2026, 5:35 PM CET
Carl Zeiss Meditec AG Market Cap
Carl Zeiss Meditec AG has a market cap or net worth of €2.82 billion as of September 3, 2026. Its market cap has decreased by -25.21% in one year.
Market Cap
2.82B
Enterprise Value
3.38B
Revenue
2.18B
Ranking
n/a
PE Ratio
23.06
Stock Price
€32.16
ChartMarket Cap Chart
Since July 30, 2002, Carl Zeiss Meditec AG's market cap has increased from 281.58M to 2.82B, an increase of 899.76%. That is a compound annual growth rate of 10.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 2.82B | -19.60% |
| Dec 30, 2025 | 3.50B | -12.13% |
| Dec 30, 2024 | 3.98B | -54.93% |
| Dec 29, 2023 | 8.84B | -16.17% |
| Dec 30, 2022 | 10.55B | -36.22% |
| Dec 30, 2021 | 16.53B | 69.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 59.93B |
| Bayer Aktiengesellschaft | 48.47B |
| Siemens Healthineers AG | 43.20B |
| Fresenius SE & Co. KGaA | 24.91B |
| Ottobock SE & Co. KGaA | 3.78B |
| SCHOTT Pharma AG & Co. KGaA | 3.51B |
| Fielmann Group AG | 3.29B |
| Dermapharm Holding SE | 1.93B |